BridgeBio Pharma Announces Positive Phase 2 Data For Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Monday, March 14, 2022 1 min read

Key Takeaway: BridgeBio Pharma Announces Positive Phase 2 Data For Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Full Press Release Details

BridgeBio Pharma Announces Positive Phase 2 Data For Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I).